Conduit Pharmaceuticals Inc. (NASDAQ:CDT) Short Interest Down 67.6% in December

Conduit Pharmaceuticals Inc. (NASDAQ:CDT) saw a large drop in short interest during the month of December. As of December 31st, there was short interest totalling 3,750,000 shares, a drop of 67.6% from the December 15th total of 11,570,000 shares. Based on an average daily trading volume, of 52,100,000 shares, the days-to-cover ratio is presently 0.1 days.

Conduit Pharmaceuticals Stock Performance

Shares of CDT stock traded up $0.00 on Tuesday, hitting $0.10. The company had a trading volume of 20,789,693 shares, compared to its average volume of 225,430,375. Conduit Pharmaceuticals has a twelve month low of $0.05 and a twelve month high of $4.09. The company has a 50-day moving average price of $0.09 and a 200-day moving average price of $0.16.

Conduit Pharmaceuticals Company Profile

Conduit Pharmaceuticals Inc, a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.